Online health and wellness company Hims & Hers raised $1 billion through convertible senior notes to grow its international ...

NVDA (Nvidia). Sell to hold by Cavenagh Research. "Despite earlier concerns, demand-related downside risks have largely ...

There's a well-known saying in the investing world, which advises investors to "sell in May and go away." Historically, that ...

Hims research determined which fast food burgers have the healthiest nutritional content and which ones to save for a special ...

In this week’s edition of InnovationRx, we look at Trump's drug pricing executive order, how the cofounder of Hims became a ...

CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.

Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...

Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy.

Volatility in the economy is causing digital health companies to rethink their strategies for the remainder of 2025.

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...